Trial intelligence / Profile preview

Vitamin C for Hospitalized COVID-19 Patients (LOVIT-COVID)

NCT04401150Phase 3Completed

Sponsor
Université de Sherbrooke
Start
Aug 2020
Primary completion
Jul 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of ascorbic acid in coronavirus disease 2019 (COVID-19), sponsored by Université de Sherbrooke. Started Aug 2020; status: completed.

02

Drugs

ascorbic acid
03

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on NCT04401150.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04401150.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call